Our Mission: Cure Desmoid Tumors
The Desmoid Tumor Research Foundation (DTRF) empowers and unites everyone committed to finding answers for the desmoid tumor community. We aggressively fund desmoid tumor research, accelerate the development of improved therapies, drive collaborations among clinicians and researchers worldwide, and support patients and doctors through education. Our goal is to find a cure for each and every patient diagnosed with this rare disease.
Learn more about submitting a grant proposal.
EXPLORE THE RESEARCH WE’VE FUNDED AT PRESTIGIOUS INSTITUTIONS AROUND THE WORLD.
| Year | Principal Investigator | Award Title | |
|---|---|---|---|
| Year2018 | Principal InvestigatorBenjamin Alman, MD, Duke University | Award Title“A genetically targeted mouse model of desmoid tumors.” Year 1 of 1. | View Project |
| Year2018 | Principal InvestigatorBenjamin Alman, MD, Duke University and Kelly Mercier, PhD, RTI International, | Award Title“Stable isotope resolved metabolomics to interrogate the interactions between stroma and desmoid tumors.” Year 1 of 2 | View Project |
| Year2018 | Principal InvestigatorRaphael E. Pollock, MD, PhD, The Ohio State University | Award Title“The role of the tumor microenvironment in S45F desmoid tumor chemotherapeutic resistance.” Year 1 of 2. | View Project |
| Year2018 | Principal InvestigatorGerlinde Wernig, MD, Assistant Professor of Pathology, Stanford University School of Medicine | Award Title“c-Jun-inducible mice, to study the pathomechanism of desmoid-type fibromatosis in vivo with particular attention to the role of b-catenin/wnt and Notch pathways.” Year 1 of 2 | View Project |
| Year2017 | Principal InvestigatorBreelyn Wilky, MD, University of Miami | Award Title“Correlation of CTNNB1 mutation status with chemotherapy response by MRI in patients with desmoid tumors.” Year 2 of 2 | View Project |
| Year2017 | Principal InvestigatorKris Vleminckx, PhD, Ghent University, Belgium | Award Title“Identifying targets for therapy in a novel genetic Xenopus model for desmoid tumor formation.” Year 2 of 3 | View Project |
| Year2017 | Principal InvestigatorMatt van de Rijn, MD, PhD, Stanford University | Award Title“Next generation sequencing approach to desmoid tumors.” Year 3 of 3 | View Project |
| Year2017 | Principal InvestigatorDaniela Segat, PhD, ''Mauro Baschirotto'' Institute for Rare Diseases - B.I.R.D. Foundation, Italy | Award Title“In vitro study of the involvement of cell-cell and cell-matrix and focal adhesion formation in desmoid-type fibromatosis myofibroblastic differentiation under pro-inflammatory stimuli.” Year 1 of 1 | View Project |
| Year2017 | Principal InvestigatorRaphael E. Pollock, MD, PhD, The Ohio State University | Award Title“Reactivating apoptosis: a potential therapeutic target for desmoid tumors with CTNNB1 S45F mutation.” Year 3 of 3 | View Project |
| Year2017 | Principal InvestigatorYoshihiro Nishida, MD, PhD, Nagoya University Graduate School of Medicine | Award Title“Effects of mechanical forces on the cell and tumor behavior of desmoid-type fibromatosis.” Year 1 of 1 | View Project |
Clinicians & Researchers Newsletter
Receive monthly updates about treatment advances, grant applications, clinical trials, CME opportunities, and more.
